Houston, TX, United States of America

Nicholas Simmons


 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Nicholas Simmons

Introduction

Nicholas Simmons is a notable inventor based in Houston, Texas. He has made significant contributions to the field of medical research, particularly in the development of compounds for treating bacterial infections. With a total of three patents to his name, Simmons has demonstrated a commitment to advancing healthcare through innovative solutions.

Latest Patents

Simmons' latest patents include groundbreaking work on compounds and methods for treating or preventing bacterial infections. This patent focuses on compounds that can inhibit β-lactamases, including OXA enzymes such as OXA-24, OXA-48, and OXA-58. These compounds have potential applications in both in vitro and in vivo settings. Another significant patent involves the preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside, detailing processes for their preparation and the compositions that include these compounds.

Career Highlights

Throughout his career, Nicholas Simmons has worked with prestigious institutions such as the University of Pennsylvania and Baylor College of Medicine. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to important research initiatives.

Collaborations

Simmons has collaborated with notable colleagues, including Melpo Christofidou-Solomidou and Kyriacos Costa Nicolaou. These partnerships have further enriched his research and innovation efforts.

Conclusion

Nicholas Simmons is a distinguished inventor whose work has the potential to impact the medical field significantly. His patents reflect a dedication to addressing critical health challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…